Log in to search using one of your social media accounts:

 

Combination drug regimen may benefit patients with hepatitis C
(The JAMA Network Journals) Treatment of chronic hepatitis C virus genotype 1 infection with the interferon-free regimen of sofosbuvir and ribavirin resulted in a high sustained virologic response rate in a patient population with unfavorable treatment characteristics, according to a study in the August 28 issue of JAMA. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 27, 2013 Category: Infectious Diseases Source Type: news

New intervention reduces risky sex among bisexual African-American men
A culturally tailored HIV prevention program developed and tested by investigators at UCLA and the Charles R. Drew University of Medicine and Science has been shown to significantly reduce unprotected sex among bisexual black men.   The innovative approach, called Men of African American Legacy Empowering Self, or MAALES, is described in an article in the peer-reviewed journal AIDS.   The rate of HIV/AIDS among African-Americans is significantly higher than it is among any other ethnic or racial group. (According to the Centers for Disease Control and Prevention, African-Americans accounted for an estimated 44 pe...
Source: UCLA Newsroom: Health Sciences - August 21, 2013 Category: Universities & Medical Training Source Type: news

HCV: Interferon-Free Regimen Works in Over 50% of PatientsHCV: Interferon-Free Regimen Works in Over 50% of Patients
More than half (52% - 69%) of patients with HCV treated with faldaprevir combined with deleobuvir plus ribavirin had sustained virologic response 12 weeks after treatment completion. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 14, 2013 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Liver Transplantation for HIV/HCV CoinfectionLiver Transplantation for HIV/HCV Coinfection
Should liver transplant be contraindicated for HIV/HCV coinfected patients? Future Virology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 12, 2013 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Anti-herpesvirus drug treatment may benefit some chronic fatigue syndrome patients
Many experts believe that chronic fatigue syndrome (CFS) has several root causes including some viruses. Now, lead scientists Shara Pantry, Maria Medveczky and Peter Medveczky of the University of South Florida's Morsani College of Medicine, along with the help of several collaborating scientists and clinicians, have published an article in the Journal of Medical Virology suggesting that a common virus, Human Herpesvirus 6 (HHV-6), is the possible cause of some CFS cases... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 30, 2013 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Anti-herpes virus drug treatment may benefit some chronic fatigue syndrome patients
Many experts believe that chronic fatigue syndrome (CFS) has several root causes including some viruses. Now, lead scientists Shara Pantry, Maria Medveczky and Peter Medveczky of the University of South Florida's Morsani College of Medicine, along with the help of several collaborating scientists and clinicians, have published an article in the Journal of Medical Virology suggesting that a common virus, Human Herpesvirus 6 (HHV-6), is the possible cause of some CFS cases... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 30, 2013 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Researchers reveal monoclonal antibody effective against norovirus
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) provide the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research, which could one day lead to effective therapies against the virus, was published online ahead of print in the Journal of Virology. "We initiated this work because there is presently no virus-specific treatment or vaccine to control the norovirus illness," says Kim Y. Green, a researcher on the study... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 27, 2013 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Inherited virus can cause cognitive dysfunction and fatigue
(University of South Florida (USF Health)) Many experts believe that chronic fatigue syndrome (CFS) has several root causes including some viruses. Now, lead researchers at the University of South Florida, along with the help of several collaborating scientists and clinicians, have published an article in the Journal of Medical Virology suggesting that a common virus, Human Herpesvirus 6, may cause some CFS cases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 26, 2013 Category: Global & Universal Source Type: news

Monoclonal antibody effective against norovirus
(American Society for Microbiology) Researchers from the National Institute of Allergy and Infectious Diseases provide the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research, which could one day lead to effective therapies against the virus, was published online ahead of print in the Journal of Virology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2013 Category: Global & Universal Source Type: news

Unusual Tick-Borne Virus Lurks In Missouri's Woods
Last year, virologists traced the mysterious illness of two Missouri farmers to a virus never seen before. Now, scientists have found the so-called Heartland virus in ticks. The discovery means the U.S. has another tick-borne illness on its hands — and "another reason to avoid getting bit."» E-Mail This     » Add to Del.icio.us (Source: NPR Health and Science)
Source: NPR Health and Science - July 23, 2013 Category: Consumer Health News Source Type: news

Review article describes epidemiology, characteristics and prevention of West Nile virus
(The JAMA Network Journals) Lyle R. Petersen, M.D., M.P.H., of the Centers for Disease Control and Prevention, US Public Health Service, Department of Health and Human Services, Fort Collins, Colo., and colleagues conducted a review of the medical literature and national surveillance data to examine the ecology, virology, epidemiology, clinical characteristics, diagnosis, prevention, and control of West Nile virus. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 16, 2013 Category: Infectious Diseases Source Type: news

General DNA Sequencing Can Reveal Previously Undetectable HPV
There are 170 established HPV types. Cancerous human papillomavirus (HPV) viruses are the main cause of cervical cancer, and are found in close to 100% of cervical tumors. Cervical cancer and genital warts are caused by HPV. However, testing for the virus using standard techniques can sometimes give a negative result - in these cases, the condylomas are called 'virus-negative' warts. In a new study published in Virology, researchers assessed the DNA found in samples taken from 40 patients with 'virus-negative' genital warts... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 15, 2013 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

NIH grant lets Virginia Tech's X.J. Meng study how hepatitis E virus infects across species barrier
(Virginia Tech) X.J. Meng, a University Distinguished Professor at Virginia Tech and a virologist at the Virginia-Maryland Regional College of Veterinary Medicine, has received a four-year, nearly $1.6 million grant from the National Institutes of Health to better understand the genetic elements that allow hepatitis E virus to transfer from animals to people. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2013 Category: Global & Universal Source Type: news

10 Postdoctoral Fellowships in Cancer Research, Heidelberg, Germany
Added via NatureJobs. The German Cancer Research Center (DKFZ) invites applications for 10 two-year Postdoctoral Fellowships in Cancer Research. This Program provides interdisciplinary training and research opportunities in state-of-the-art research facilities for excellent young scientists, no longer than 2 years past graduation, who wish to work at the forefront of cancer research in any of the following topics: Cell and Tumor Biology, Developmental and Stem Cell Biology; Functional and Structural Genomics, Systems Biology; Epidemiology, Cancer Risk Factors, Cancer Epigenomics; Tumor Immunology; Infection and Cancer, Tum...
Source: Society for Endocrinology - July 12, 2013 Category: Endocrinology Source Type: news

Higher Virologic Failure Reported for Children on NevirapineHigher Virologic Failure Reported for Children on Nevirapine
For children with HIV, a nevirapine-based regimen results in more virologic failures after 5 years than other treatment options. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 11, 2013 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news

Vitamin D and HIV InfectionVitamin D and HIV Infection
What impact does vitamin D supplementation have on HIV infected persons? Future Virology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 11, 2013 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Hidden strains of HPV found in 'virus-negative' genital warts
(Elsevier) In a new study published in Virology, researchers assessed the DNA found in samples taken from 40 patients with 'virus-negative' genital warts. Through a general DNA sequencing approach, the researchers showed that several of the negative samples did in fact contain HPV DNA. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 11, 2013 Category: Global & Universal Source Type: news

New Books Party: books received this week | @GrrlScientist
This week, I tell you about a treasure trove of excellent science books, including books about evolution, pterosaurs, birds, human sexuality, HIV/AIDS and chemistry.Below the jump, I mention the books that I received recently in the mail as gifts or as review copies, or that I purchased somewhere. These are the books that I may review in more depth later, either here or in print somewhere in the world. When I get new books, I like to share them with people. Unfortunately, you are all so far away, so I cannot host a book party in my crib where you can look then over, so I'll do the next best thing. I'll host a book party on...
Source: Guardian Unlimited Science - July 5, 2013 Category: Science Authors: GrrlScientist Tags: Blogposts guardian.co.uk Science Source Type: news

The 'Gold' Standard: A Rapid, Cheap Method Of Detecting Dengue Virus
The development of an easy to use, low cost method of detecting dengue virus in mosquitoes based on gold nanoparticles is reported in BioMed Central's open access journal Virology Journal. The assay is able to detect lower levels of the virus than current tests, and is easy to transport and use in remote regions. Half the world's population is at risk of Dengue virus infection - it infects 50-100 million people per year, approximately half a million of these require hospitalization and 2.5% (most of which are children) will die... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 2, 2013 Category: Consumer Health News Tags: Medical Devices / Diagnostics Source Type: news

Molluscum contagiosum VirusMolluscum contagiosum Virus
This review highlights recent advances made in the field of molluscum contagiosum virus pathogenesis. Future Virology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 27, 2013 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Neurotoxicity of Antiretroviral TherapyNeurotoxicity of Antiretroviral Therapy
Which antiretrovirals are preferable in patients with HIV-associated neurologic complications? Future Virology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 13, 2013 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Primary Efficacy and Safety Findings from Four Phase 3 Japanese Studies of Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Adult Patients (Jun 6, 2013)
CORK, Ireland (June 6, 2013) -- Janssen R&D Ireland (Janssen) today announced primary efficacy and safety results from four Japanese Phase 3 clinical studies demonstrating that the use of the investigational NS3/4A protease inhibitor simeprevir (TMC435) led to sustained virologic response 12 weeks after the end of treatment (SVR12) in patients with genotype 1 hepatitis C, when administered once daily with pegylated interferon and ribavirin. The four studies examined the use of simeprevir in patients who were treatment na?ve, as well as patients who were non-responders to prior therapy or relapsed following treatment wi...
Source: Johnson and Johnson - June 6, 2013 Category: Pharmaceuticals Source Type: news

Nigeria: 'Over 3000 Persons Living With Multi Drug Resistant TB'
[Daily Trust]Dr Patrick Dakum is the chief executive officer of the Institute of Human Virology in Nigeria. In this interview, he speaks on the prevalence of MDR TB and the institute's efforts to curb and prevent its spread (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - June 5, 2013 Category: Infectious Diseases Source Type: news

In Mouse Models, New Agent Inhibits HCV Replication
Treatments against hepatitis C virus have only been partially successful. A major problem is that antivirals generate drug resistance. Now Seong-Wook Lee of Dankook University, Yongin, Republic of Korea and his collaborators have developed agents that bind to the business end of a critical protein, disabling it so successfully that no resistance has arisen. The research is published in the June 2013 issue of the Journal of Virology. The target protein for the new agents is the NS5B replicase protein, which is the central catalytic enzyme in HCV replication... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 3, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Protection Against Post-Influenza Bacterial Superinfection Offered By Interleukin-22
Researchers from the Pasteur Institute, Lille, France have shown in a mouse model that interleukin-22 protects against bacterial superinfections that can arise following influenza. Their research is published in the June 2013 issue of the Journal of Virology. Influenza A viral infection can lead to primary pneumonia and, later on, to serious complications including secondary bacterial pneumonia and sepsis. Post-influenza bacterial superinfections that occur during seasonal epidemics and pandemics are of great concern to human health and impose a considerable socio-economic burden... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 3, 2013 Category: Consumer Health News Tags: Flu / Cold / SARS Source Type: news

No Benefit Of Double Dose Antiviral Drug For Severe Influenza
Findings have major implications for stockpiling drugs during pandemics, say experts There are no virological or clinical benefits of giving double doses of the antiviral drug oseltamivir (Tamiflu) to patients admitted to hospital with severe influenza, finds a large study from South East Asia published on bmj.com today. This is the first study to examine the effectiveness of higher doses of oseltamivir in cases of hospitalized severe human influenza (seasonal, pandemic and bird flu strains)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 31, 2013 Category: Consumer Health News Tags: Flu / Cold / SARS Source Type: news

New agent inhibits HCV replication in mouse models -- No resistance seen
(American Society for Microbiology) Treatments against hepatitis C virus have only been partially successful. A major problem is that antivirals generate drug resistance. Now Seong-Wook Lee of Dankook University, Yongin, Republic of Korea and his collaborators have developed agents that bind to the business end of a critical protein, disabling it so successfully that no resistance has arisen. The research is published in the June 2013 issue of the Journal of Virology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 30, 2013 Category: Global & Universal Source Type: news

Interleukin-22 protects against post-influenza bacterial superinfection
(American Society for Microbiology) Researchers from the Pasteur Institute, Lille, France have shown in a mouse model that interleukin-22 protects against bacterial superinfections that can arise following influenza. Their research is published in the June 2013 issue of the Journal of Virology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 30, 2013 Category: Global & Universal Source Type: news

Double dose of antiviral drug offers no added benefit in severe influenza
(Wellcome Trust) Giving double doses of the antiviral drug oseltamivir, or Tamiflu, offers no clinical or virological advantages over a standard dose for patients admitted to hospital with severe influenza infection, according to a randomized trial published today and funded by the Wellcome Trust, US National Institute of Allergy and Infectious Diseases and the Singapore National Medical Research Council. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 30, 2013 Category: Infectious Diseases Source Type: news

Drug Resistance To Tamiflu Confirmed For H7N9 Virus
Resistance to treatment with Tamiflu (oseltamivir) and similar drugs in people who have the H7N9 flu virus has now been confirmed, according to new research published in The Lancet. Described as one of the most detailed virological studies of the H7N9 virus to date, the study was led by Dr Zhenghong Yuang of the Shanghai Public Health Clinical Centre and School of Basic Medical Sciences, Shanghai Medical College of Fudan University, China, and Dr Malik Peiris, of the University of Hong Kong, China... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 29, 2013 Category: Consumer Health News Tags: Flu / Cold / SARS Source Type: news

IL-21 Signals Important For Antibody-Producing Cells And T Helper Cells That Support Them
Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections. The results are published in the Journal of Virology. "Our findings highlight how IL-21 could be important in the development of antiviral vaccines," says research associate Ata Ur Rasheed Mohammed, PhD, the first author of the paper. The senior author is Rafi Ahmed, PhD, director of the Emory Vaccine Center and a Georgia Research Alliance Eminent Scholar... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 28, 2013 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Computer Model Predicts When Viruses Become Infectious
A new computer model could help scientists predict when a particular strain of avian influenza might become infectious from bird to human, according to a report to be published in the International Journal Data Mining and Bioinformatics. Chuang Ma of the University of Arizona, Tucson, and colleagues at the Huazhong University of Science and Technology, Wuhan and the Wuhan Institute of Virology, explain that since 1997 several strains of avian influenza A virus (AIV), commonly known as "bird flu" have infected people directly from their natural bird hosts leading to numerous deaths... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 23, 2013 Category: Consumer Health News Tags: Bird Flu / Avian Flu Source Type: news

Adverse Events Common With Triple Therapy in HCV CirrhosisAdverse Events Common With Triple Therapy in HCV Cirrhosis
In cirrhotic patients, triple-therapy against hepatitis C virus (HCV) produces a high virological response rate, but at the cost of a high rate of serious adverse events, French researchers say. Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 22, 2013 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Evidence of host adaptation of avian-origin influenza A virus
This study will be published on Science China Life Sciences 2013, No.6. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 15, 2013 Category: Global & Universal Source Type: news

Robert Webster, Ph.D., presented with National Foundation for Infectious Diseases award
Virologist Robert G. Webster, Ph.D., of St. Jude Children’s Research Hospital, is the recipient of the Charles Mérieux Award from the National Foundation for Infectious Diseases (NFID). (Source: St. Jude Children's Research Hospital)
Source: St. Jude Children's Research Hospital - May 14, 2013 Category: Pediatrics Source Type: news

Mosquito Survey Identifies Reservoir Of Disease
A large scale, five year study of mosquitoes from different ecological regions in Kenya, including savannah grassland, semi-arid Acacia thorn bushes, and mangrove swamps, found a reservoir of viruses carried by mosquitoes (arboviruses) that are responsible for human and animal diseases. This research, published in BioMed Central's open access journal Virology Journal, highlights the need for continued surveillance in order to monitor the risk of disease outbreaks... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 10, 2013 Category: Consumer Health News Tags: Tropical Diseases Source Type: news

Faldaprevir Early Hepatitis C Treatment Success, Viral CureFaldaprevir Early Hepatitis C Treatment Success, Viral Cure
The protease inhibitor combined with interferon and ribavirin achieved virologic cure in up to 80% of patients. Many were able to stop all treatment at 24 weeks. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 8, 2013 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Tamil Nadu to set up Virology labs
Tamil Nadu government would soon set up Molecular Virology Laboratories in Medical College Hospitals in Chennai, Madurai, Coimbatore and Tirunelveli. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 8, 2013 Category: Pharmaceuticals Source Type: news

Poultry trade 'may be spreading bird flu'
Poultry workers moving to and from wet markets and farms may be responsible for the spread of the deadly H7N9 virus in China, says a virologist who's working with the World Health Organization to investigate the outbreak. (Source: WDSU.com - Health)
Source: WDSU.com - Health - May 6, 2013 Category: Consumer Health News Source Type: news

New bird flu strain requires vigilance researchers warn
Conclusion This is important research tracking the origins of the new H7N9 bird flu virus, which gives some clues about how it might behave in the future. Scientists are particularly concerned that a future mutation could mean it is transmitted between humans, which increases the risk of a pandemic (an epidemic of infection across countries or continents). For travellers to China and other countries affected by bird flu, it's important to observe the following precautions: avoid visiting live animal markets and poultry farms avoid contact with surfaces that are contaminated with animal faeces don't eat or handle u...
Source: NHS News Feed - May 2, 2013 Category: Consumer Health News Tags: Genetics/stem cells Medical practice Source Type: news

Nigeria: Tomori Tasks President Jonathan On Polio Eradication
[Vanguard]As Nigeria battles rejection of polio vaccination in the North, renowned Virologist, Professor Oyewale Tomori has alleged that Nigerian leaders are yet to show enough commitment needed to attain the global eradication deadline by 2018. (Source: AllAfrica News: Polio)
Source: AllAfrica News: Polio - April 30, 2013 Category: Infectious Diseases Source Type: news

Antiretroviral regimen associated with less virological failure among HIV-infected children
(The JAMA Network Journals) Elizabeth D. Lowenthal, M.D., M.S.C.E., of the University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, and colleagues conducted a study to determine whether there was a difference in time to virological failure between HIV-infected children initiating nevirapine vs. efavirenz-based antiretroviral treatment in Botswana. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 30, 2013 Category: Global & Universal Source Type: news